2019 SESSION OF THE
MARYLAND GENERAL ASSEMBLY
| | | |
| 2019 SESSION OF THE |
| Volume 25, Number 8 | March 13, 2019 |
Here are some of the hot issues as the 2019 Legislative Session develops:
BILLS INTRODUCED
Health Care Administration & Finance HB520/SB406 Prenatal and Infant Care Coordination - Grant Funding and Task Force Requiring the Governor to include $5,000,000 in the annual budget beginning in fiscal year 2021 for the Maryland Prenatal and Infant Care Coordination Services Grant Program Fund; establishing the Task Force on Maryland Maternal and Child Health; requiring the Task Force to study and make recommendations regarding certain matters; requiring the Task Force to report its findings and recommendations to the General Assembly on or before November 1, 2019; etc. Hearing Date: Wed 2/27 1:00 PM Effective Date: July 1, 2019, October 1, 2019 SB1045 Maryland Health Insurance Plan Fund - Use of Remaining Balance Altering the fiscal years, from 2016 through 2019 to 2020 through 2022, in which the remaining fund balance in the Maryland Health Insurance Plan Fund obtained from the federal Medicare program or the Medicaid program may be used for certain activities related to high-needs Medicare and dually eligible individuals; etc. Hearing Date: Effective Date: July 1, 2019 [GO TO TOP] [GO TO BILL LIST] HB696/SB430 Maryland Health Care Commission - Authorized Prescribers - Reporting of Financial Gratuities or Incentives Requiring each authorized prescriber who receives a financial gratuity or incentive from a pharmaceutical distributor or manufacturer to file a certain disclosure form with the Maryland Health Care Commission within 30 days of the receipt of the financial gratuity or incentive; authorizing the Commission to impose a certain fine under certain circumstances; requiring the Commission to adopt certain regulations; defining certain terms; and providing for the application of the Act. Hearing Date: Thu 2/21 1:00 PM Effective Date: October 1, 2019 [GO TO TOP] [GO TO BILL LIST] SB1039/HB1324 Maryland Medical Assistance Program and Managed Care Organizations That Use Pharmacy Benefits Managers - Reimbursement Requirements Requiring the Maryland Medical Assistance Program to establish reimbursement levels, rather than maximum reimbursement levels, for certain drug products; requiring that certain minimum reimbursement levels be at least equal to the National Average Drug Acquisition Cost of the generic product plus a certain fee-for-service professional dispensing fee; providing that certain provisions of the Act apply to managed care organizations that use pharmacy benefits managers to manage prescription drug coverage; etc. Hearing Date: Effective Date: October 1, 2019 [GO TO TOP] [GO TO BILL LIST] SB1039/HB1324 Maryland Medical Assistance Program and Managed Care Organizations That Use Pharmacy Benefits Managers - Reimbursement Requirements Requiring the Maryland Medical Assistance Program to establish reimbursement levels, rather than maximum reimbursement levels, for certain drug products; requiring that certain minimum reimbursement levels be at least equal to the National Average Drug Acquisition Cost of the generic product plus a certain fee-for-service professional dispensing fee; providing that certain provisions of the Act apply to managed care organizations that use pharmacy benefits managers to manage prescription drug coverage; etc. Hearing Date: Effective Date: October 1, 2019 SB1045 Maryland Health Insurance Plan Fund - Use of Remaining Balance Altering the fiscal years, from 2016 through 2019 to 2020 through 2022, in which the remaining fund balance in the Maryland Health Insurance Plan Fund obtained from the federal Medicare program or the Medicaid program may be used for certain activities related to high-needs Medicare and dually eligible individuals; etc. Hearing Date: Effective Date: July 1, 2019 [GO TO TOP] [GO TO BILL LIST] SB1039/HB1324 Maryland Medical Assistance Program and Managed Care Organizations That Use Pharmacy Benefits Managers - Reimbursement Requirements Requiring the Maryland Medical Assistance Program to establish reimbursement levels, rather than maximum reimbursement levels, for certain drug products; requiring that certain minimum reimbursement levels be at least equal to the National Average Drug Acquisition Cost of the generic product plus a certain fee-for-service professional dispensing fee; providing that certain provisions of the Act apply to managed care organizations that use pharmacy benefits managers to manage prescription drug coverage; etc. Hearing Date: Effective Date: October 1, 2019 Legislative Session Office Legislative Hotline is a service of Johns Hopkins Government Affairs. © 2019 The Johns Hopkins Institutions. Baltimore, Maryland.
For more information, please contact: Patrick Carlson
For more information, please contact: Patrick Carlson
Health Care Occupations
For more information, please contact: Patrick Carlson
Health Insurance/Health Care Access
For more information, please contact: Patrick Carlson
Medicaid
For more information, please contact: Patrick Carlson
For more information, please contact: Patrick Carlson
Pharmaceuticals
For more information, please contact: Patrick Carlson
STAFF CONTACT INFORMATION
Please contact Government Relations if you have concerns or would like additional information. Your input assists us greatly in evaluating and formulating the position of Johns Hopkins on all legislation.
47 State Circle, Suite 203
Annapolis, MD 21401
410-269-0057
fax 410-269-1574
Patrick Carlson [email protected] Mary Clapsaddle [email protected] Annie Coble [email protected] Mickey Geisler [email protected] Sally Guy [email protected] Sheila Higdon [email protected]
[GO TO TOP] [GO TO BILL LIST]
ACRONYMS
Office of Government and Community Affairs.